Year: 2024

Company announcement no. 49 2024  Group CommunicationsBernstorffsgade 40DK-1577 København VTel. +45 45 14 00 00 4 November 2024Danske Bank share buy-back programme: Transactions in week 44 On 2 February 2024, Danske Bank A/S announced a share buy-back programme for a total of DKK 5.5 billion, with a maximum of 70 million shares, in the period from 5 February 2024 to 31 January 2025, at the latest, as described in company announcement no. 2 2024. The programme is being carried out under Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbour Rules. The following transactions were made under the share buy-back programme in week 44:  Number of shares VWAP DKK Gross valueDKKAccumulated,...

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR  Clariant committed to creating shareholder value as a top quartile specialty chemical company Differentiated segment steering and adoption of strategic mandates to drive above-market growth Innovation arenas to deliver ~ 70 % of profitable growth and innovation rate expected to reach ~ 20 % by 2027 Reinforced medium-term financial targets, by 2027 at the latest: compound annual sales growth of 4 – 6 % in local currency, EBITDA margin of 19 – 21 %, and free cash flow conversion of around 40 % Margin improvement reinforced by new self-help actions totaling ~ CHF 80 million run-rate savings in full by latest 2027 Upgraded 2030 non-financial targets, including increased GHG emission reduction targets in line with SBTi 1.5°C scenario “At Clariant, we have built...

HOUSTON, Nov. 03, 2024 (GLOBE NEWSWIRE) — Talen Energy Corporation (“Talen”) (NASDAQ: TLN) released the following statement in response to Friday’s Federal Energy Regulatory Commission (the “FERC”) order rejecting the amended Susquehanna Interconnection Service Agreement (“ISA”) between PJM Interconnection (“PJM”), PPL Electric Utilities (“PPL”), and Talen which would increase co-located load capacity at Talen’s Susquehanna nuclear power generation facility from 300 megawatts to 480 megawatts: On Friday, FERC issued an order denying PJM, PPL, and Talen’s Susquehanna ISA. Talen believes FERC erred and we are evaluating our options, with a focus on commercial solutions. We believe this ISA amendment is just and reasonable and in the best interest of consumers. FERC’s decision will have a chilling effect on economic development...

MELBOURNE, Australia, Nov. 04, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today welcomes the announcement by the United States (U.S.) Centers for Medicare & Medicaid Services (CMS) that it will pay separately for specialized diagnostic radiopharmaceuticals1 for Medicare Fee for Service patients in the hospital outpatient setting, beyond the transitional pass-through payment period (“pass-through”). This is a significant decision for patients and hospitals, with the change facilitating equitable access to advanced imaging agents for all patients into the future.  In 2025, the separate payments under the Hospital Outpatient Prospective Payment System (OPPS) will be based on Mean Unit Cost (MUC), derived from hospital claims data and apply to any specialized diagnostic radiopharmaceutical...

LEHI, Utah, Nov. 03, 2024 (GLOBE NEWSWIRE) — Complete Solar Holdings, Inc. d/b/a Complete Solar (“Complete Solar” or the “Company”) (Nasdaq: CSLR), a solar technology, services, and installation company, today announced it will release its financial and operational results, for the third quarter of 2024, after market close on Wednesday, November 13, 2024. T.J. Rodgers and the Complete Solar management team will also host a webcast conference call on November 13, 2024, at 5:00 PM ET. Interested parties may access the webcast by registering here, or by visiting the Events page within the Investor Relations section of Complete Solar’s company website at: https://investors.completesolar.com/news-events/events. Please log into the webcast at least 10 minutes prior to the start of the event. A replay of the webcast will be available...

SAN DIEGO, Nov. 03, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announces the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 651,380 ordinary shares of the Company originally issued in April 2024, at an exercise price of US$44.14 per share. The gross proceeds to the Company from the exercise of the warrants are expected to be approximately US$28.75 million. The Company intends to use the net proceeds from the offering for general corporate purposes. The ordinary shares issuable upon exercise of the warrants are registered...

CHARLOTTE, N.C., Nov. 02, 2024 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, announced today that Harold Bevis, President and Chief Executive Officer, and Chris Bohnert, Senior Vice President and Chief Financial Officer, will be presenting at the Gabelli Funds 48th Annual Automotive Symposium on November 4, 2024 in Las Vegas. The presentation will begin at 11:20 a.m. PT (2:20 p.m. ET) on Monday, November 4, 2024. Investors interested in accessing the Company’s presentation may register to access the live event here. All registrants will receive a link to the event upon registration. A link to the presentation and associated materials can also be accessed through the investor section of the Company’s website at www.nninc.com. In...

NEW YORK, Nov. 02, 2024 (GLOBE NEWSWIRE) — JP 3E Holdings, Inc. (“JP3E”), formerly known as Spooz, Inc. (OTC: SPZI), is clarifying the press release issued on October 31, 2024. JP3E has no interest in the transaction with Öztürk Holding, LLC. JP3E is involved with executing EB-5 funding for Kerogen II only.  To receive information on JP3E, sign up for email news alerts at https://www.jp3e.com/subscription. For additional information on the Global Trade Financing Platform via Bloxcross, Inc., contact sgallegos@bloxcross.com. About JP 3E Holdings, Inc. JP3E is a global leader in commodity trading, known for its innovative approach to optimizing trade processes and solutions across numerous sectors. With a commitment to sustainability and market leadership, JP3E continues to drive new trends and solutions in global commodity markets. About...